Anti-FLT3 CAR T-cell Therapy in FLT3 Positive Relapsed/Refractory Acute Myeloid Leukemia

NCT05023707 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
5
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators